18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Circulating bile acids predict outcome in critically ill patients

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Jaundice and cholestatic hepatic dysfunction are frequent findings in critically ill patients associated with increased mortality. Cholestasis in critically ill patients is closely associated with stimulation of pro-inflammatory cytokines resulting in impaired bile secretion and subsequent accumulation of bile acids.

          Aim of this study was to evaluate the clinical role of circulating bile acids in critically ill patients.

          Methods

          Total and individual serum bile acids were assessed via high-performance liquid chromatography in 320 critically ill patients and 19 controls.

          Results

          Total serum bile acids were threefold higher in septic than cardiogenic shock patients and sixfold higher than in post-surgical patients or controls ( p < 0.001). Elevated bile acid levels correlated with severity of illness, renal dysfunction and inflammation ( p < 0.05). Total bile acids predicted 28-day mortality independently of sex, age, serum bilirubin and severity of illness (HR 1.041, 95% CI 1.013–1.071, p < 0.005). Best prediction of mortality of total bile acids was seen in patients suffering from septic shock.

          Conclusions

          Individual and total BAs are elevated by various degrees in different shock conditions. BAs represent an early predictor of short-term survival in a mixed cohort of ICU patients and may serve as marker for early risk stratification in critically ill patients. Future studies should elucidate whether modulation of BA metabolism and signalling influences the clinical course and outcome in critically ill patients.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s13613-017-0272-7) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: not found

          A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.

          To develop and validate a new Simplified Acute Physiology Score, the SAPS II, from a large sample of surgical and medical patients, and to provide a method to convert the score to a probability of hospital mortality. The SAPS II and the probability of hospital mortality were developed and validated using data from consecutive admissions to 137 adult medical and/or surgical intensive care units in 12 countries. The 13,152 patients were randomly divided into developmental (65%) and validation (35%) samples. Patients younger than 18 years, burn patients, coronary care patients, and cardiac surgery patients were excluded. Vital status at hospital discharge. The SAPS II includes only 17 variables: 12 physiology variables, age, type of admission (scheduled surgical, unscheduled surgical, or medical), and three underlying disease variables (acquired immunodeficiency syndrome, metastatic cancer, and hematologic malignancy). Goodness-of-fit tests indicated that the model performed well in the developmental sample and validated well in an independent sample of patients (P = .883 and P = .104 in the developmental and validation samples, respectively). The area under the receiver operating characteristic curve was 0.88 in the developmental sample and 0.86 in the validation sample. The SAPS II, based on a large international sample of patients, provides an estimate of the risk of death without having to specify a primary diagnosis. This is a starting point for future evaluation of the efficiency of intensive care units.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.

            The 7α-dehydroxylation of primary bile acids (BAs), chenodeoxycholic (CDCA) and cholic acid (CA) into the secondary BAs, lithocholic (LCA) and deoxycholic acid (DCA), is a key function of the gut microbiota. We aimed at studying the linkage between fecal BAs and gut microbiota in cirrhosis since this could help understand cirrhosis progression. Fecal microbiota were analyzed by culture-independent multitagged-pyrosequencing, fecal BAs using HPLC and serum BAs using LC-MS in controls, early (Child A) and advanced cirrhotics (Child B/C). A subgroup of early cirrhotics underwent BA and microbiota analysis before/after eight weeks of rifaximin. Cross-sectional: 47 cirrhotics (24 advanced) and 14 controls were included. In feces, advanced cirrhotics had the lowest total, secondary, secondary/primary BA ratios, and the highest primary BAs compared to early cirrhotics and controls. Secondary fecal BAs were detectable in all controls but in a significantly lower proportion of cirrhotics (p<0.002). Serum primary BAs were higher in advanced cirrhotics compared to the rest. Cirrhotics, compared to controls, had a higher Enterobacteriaceae (potentially pathogenic) but lower Lachonospiraceae, Ruminococcaceae and Blautia (7α-dehydroxylating bacteria) abundance. CDCA was positively correlated with Enterobacteriaceae (r=0.57, p<0.008) while Ruminococcaceae were positively correlated with DCA (r=0.4, p<0.05). A positive correlation between Ruminococcaceae and DCA/CA (r=0.82, p<0.012) and Blautia with LCA/CDCA (r=0.61, p<0.03) was also seen. Prospective study: post-rifaximin, six early cirrhotics had reduction in Veillonellaceae and in secondary/primary BA ratios. Cirrhosis, especially advanced disease, is associated with a decreased conversion of primary to secondary fecal BAs, which is linked to abundance of key gut microbiome taxa. Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Biliverdin reductase: a major physiologic cytoprotectant.

              Bilirubin, an abundant pigment that causes jaundice, has long lacked any clear physiologic role. It arises from enzymatic reduction by biliverdin reductase of biliverdin, a product of heme oxygenase activity. Bilirubin is a potent antioxidant that we show can protect cells from a 10,000-fold excess of H2O2. We report that bilirubin is a major physiologic antioxidant cytoprotectant. Thus, cellular depletion of bilirubin by RNA interference markedly augments tissue levels of reactive oxygen species and causes apoptotic cell death. Depletion of glutathione, generally regarded as a physiologic antioxidant cytoprotectant, elicits lesser increases in reactive oxygen species and cell death. The potent physiologic antioxidant actions of bilirubin reflect an amplification cycle whereby bilirubin, acting as an antioxidant, is itself oxidized to biliverdin and then recycled by biliverdin reductase back to bilirubin. This redox cycle may constitute the principal physiologic function of bilirubin.
                Bookmark

                Author and article information

                Contributors
                t.horvatits@uke.de
                a.drolz@uke.de
                k.rutter@uke.de
                k.roedl@uke.de
                lies.langouche@kuleuven.be
                greet.vandenberghe@kuleuven.be
                guenter.fauler@medunigraz.at
                brigitte.meyer@wienkav.at
                martin.huelsmann@meduniwien.ac.at
                gottfried.heinz@meduniwien.ac.at
                michael.trauner@meduniwien.ac.at
                0049 40 7410 57020 , v.fuhrmann@uke.de
                Journal
                Ann Intensive Care
                Ann Intensive Care
                Annals of Intensive Care
                Springer Paris (Paris )
                2110-5820
                2 May 2017
                2 May 2017
                2017
                : 7
                : 48
                Affiliations
                [1 ]ISNI 0000 0000 9259 8492, GRID grid.22937.3d, Division of Gastroenterology and Hepatology, Department Internal Medicine 3, , Medical University of Vienna, ; Vienna, Austria
                [2 ]ISNI 0000 0001 2180 3484, GRID grid.13648.38, Department of Intensive Care Medicine, , University Medical Center Hamburg-Eppendorf, ; Martinistraße 52, 20246 Hamburg, Germany
                [3 ]ISNI 0000 0001 0668 7884, GRID grid.5596.f, Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, , KU Leuven, ; Louvain, Belgium
                [4 ]ISNI 0000 0000 8988 2476, GRID grid.11598.34, Clinical Institute of Medical and Chemical Laboratory Diagnostics, , Medical University of Graz, ; Graz, Austria
                [5 ]GRID grid.414836.c, 5th Medical Department, , Kaiser Franz Josef Spital - SMZ Süd, ; Vienna, Austria
                [6 ]ISNI 0000 0000 9259 8492, GRID grid.22937.3d, Division of Cardiology, Department Internal Medicine 2, , Medical University of Vienna, ; Vienna, Austria
                Article
                272
                10.1186/s13613-017-0272-7
                5413465
                28466463
                af8cd639-850b-4a21-8f32-af53acadf19d
                © The Author(s) 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 4 December 2016
                : 20 April 2017
                Categories
                Research
                Custom metadata
                © The Author(s) 2017

                Emergency medicine & Trauma
                bile acids,cholestasis,cardiogenic shock,septic shock,critically ill patients,icu

                Comments

                Comment on this article